SRPT
Sarepta Therapeutics Inc
NASDAQ · Biotechnology
$18.50
+1.47 (+8.63%)
Open$17.59
Previous Close$17.03
Day High$18.64
Day Low$17.51
52W High$119.27
52W Low$10.42
Volume—
Avg Volume3.25M
Market Cap1.94B
P/E Ratio—
EPS$-3.35
SectorBiotechnology
Analyst Ratings
Hold
33 analysts
Price Target
+115.1% upside
Current
$18.50
$18.50
Target
$39.80
$39.80
$34.71
$39.80 avg
$61.57
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 1.85B | 1.33B | 612.32M |
| Net Income | 228.51M | 147.51M | -129,265,237 |
| Profit Margin | 12.4% | 11.8% | -21.1% |
| EBITDA | 251.36M | 171.28M | -118,528,387 |
| Free Cash Flow | — | — | -131,122,574 |
| Rev Growth | +39.4% | +39.4% | -6.8% |
| Debt/Equity | 0.74 | 0.74 | 0.56 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |